US Patent Issued to GLIAPHARM on May 27 for "Compositions and methods of treatment for neurological disorders comprising motor neuron diseases" (Swiss Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,967, issued on May 27, was assigned to GLIAPHARM SA (Geneva).

"Compositions and methods of treatment for neurological disorders comprising motor neuron diseases" was invented by Sylvain Lengacher (Geneva), Charles Finsterwald (Geneva) and Pierre Magistretti (Geneva).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention, in at least some embodiments, relates to an inventive molecule, compositions comprising same, and methods of use thereof for treatment of a neurological disorder."

The patent was filed on Aug. 24, 2021, under Application No. 17/409,836.

*For further information, including images, charts and tables, please visit: http://patft...